CDE Catalog | NINDS Common Data Elements

***Please contact the NINDS CDE Team (NINDSCDE@emmes.com) if you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport-Related Concussion (SRC) or Traumatic Brain Injury (TBI) as the Disease, please select a Subdisease as well.

NeuroRehab Comprehensive includes all NeuroRehab CDE recommendations. NeuroRehab General includes all NeuroRehab CDE recommendations that are not disease specific. All other NeuroRehab Subdiseases include recommendations specific to existing NINDS CDE project disorders.

Choose your Time Frame for your SRC study (Acute (time of injury until 72 hours), Subacute (after 72 hours to 3 months), and Persistent/Chronic (3 months and greater post-concussion) or Comprehensive if your study falls across the study time frames.

Choose your type of TBI study (Acute Hospitalized, Concussion/Mild TBI, Moderate/Severe TBI: Rehabilitation, or Epidemiology) or Comprehensive if your study falls outside of the study types or incorporates aspects of more than one type of study.

Search Form

Subdomain Name

CRF Name

Displaying 676 - 700 of 740

Operations

Selected 25 rows in this page.

The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
Select all	CDE ID	CDE Name	Definition	Classification	CRF Name	Copyrighted or trademarked	Disease Name	Subdisease Name
F0004-C20409	C20409	Adverse event attribution indicator	Indicator of whether the adverse event was cause by the treatment in question	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C01541	C01541	Weight measurement	Measurement of participant's weight	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C12232	C12232	Laboratory director name	Name of laboratory director where assessment was performed	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20395	C20395	Serious adverse event laboratory data text	The text that describes the relevant tests or laboratory data specific to the serious adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20403	C20403	Serious adverse event investigator assessment	Indicate the principal investigator's opinion of the cause of the event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20410	C20410	Serious adverse event not resolution indicator	Indicates whether the adverse event was not resolved	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C01581	C01581	Weight unit of measure	Unit of measure for the weight numerical value	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C17447	C17447	Event description text	The free-text field to describe the event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20396	C20396	Serious adverse event concomitant medications text	The text that describes the concomitant medications taken	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20404	C20404	Investigator assessment concurrent disorder specify text	The free-text field to specify the concurrent disorder that might have caused the serious adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20411	C20411	Serious adverse event outcome status other text	Free-text field to specify an alternate outcome attributed to the serious adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C01582	C01582	Height unit of measure	Unit of measure for the height numerical value for participant	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C18659	C18659	Unexpected adverse event indicator	The indicator of whether the adverse event is unexpected	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20397	C20397	Serious adverse event relevant history text	The text that describes relevant history including pre-existing medical conditions	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0004-C20412	C20412	Serious adverse event outcome status	Final status of the participant/subject related to the serious adverse event	Supplemental	Serious Adverse Events	False	General (For all diseases)	General (For all diseases)
F0001-C00012	C00012	Education level USA type	Highest grade or level of school participant/subject has completed or the highest degree received	Supplemental	Social Status	False	General (For all diseases)	General (For all diseases)
F0001-C00207	C00207	Marital or partner status	Status of participant/subject's current domestic relationship, whether marital or partnered	Supplemental	Social Status	False	General (For all diseases)	General (For all diseases)
F0017-C02201	C02201	Off study intervention prematurely indicator	Indicator that participant/subject discontinued study intervention before planned end of study	Supplemental	Study Discontinuation/Completion	False	General (For all diseases)	General (For all diseases)
F0017-C02202	C02202	Off study date and time	Date (and time, if applicable and known) when participant/subject completes study or is prematurely withdrawn from study (i.e., is not being followed and will not receive intervention/treatment)	Supplemental	Study Discontinuation/Completion	False	General (For all diseases)	General (For all diseases)
F0017-C02203	C02203	Off study reason	Primary reason participant/ subject is no longer participating in study (i.e., is not being followed and will not receive intervention/treatment)	Supplemental	Study Discontinuation/Completion	False	General (For all diseases)	General (For all diseases)
F0017-C02222	C02222	Off study intervention prematurely reason	Primary reason participant/subject discontinued study intervention before planned end of study	Supplemental	Study Discontinuation/Completion	False	General (For all diseases)	General (For all diseases)
F0017-C18740	C18740	Off study intervention prematurely other text	The free-text field related to 'Off study intervention prematurely reason' specifying other text. Primary reason participant/subject discontinued study intervention before planned end of study	Supplemental	Study Discontinuation/Completion	False	General (For all diseases)	General (For all diseases)
F0017-C02200	C02200	Last study intervention date and time	Date (and time, if applicable) of the last known study intervention that the participant/subject received	Supplemental	Study Discontinuation/Completion	False	General (For all diseases)	General (For all diseases)
F0022-C02010	C02010	Study drug dosage form text	Text of dosage form used to administer study drug	Supplemental	Study Drug Compliance	False	General (For all diseases)	General (For all diseases)
F0022-C02018	C02018	Study drug dispensed count	Count of amount of study drug dispensed to the participant/subject	Supplemental	Study Drug Compliance	False	General (For all diseases)	General (For all diseases)

Displaying 676 - 700 of 740

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.